discussion of penicillin, antimicrobial r&d and

19
Discussion of Penicillin, Antimicrobial R&D and Bactericide Now Initiative Prepared for CPDC Lake Alfred, FL June 12, 2014 Tom Turpen

Upload: others

Post on 11-Nov-2021

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Discussion of Penicillin, Antimicrobial R&D and

Discussion of Penicillin,Antimicrobial R&D and Bactericide Now InitiativePrepared for CPDC

Lake Alfred, FL

June 12, 2014

Tom Turpen

Page 2: Discussion of Penicillin, Antimicrobial R&D and

Outline

• Perspective – science, business, regulatory, market aspects of current challenge

• Resources and knowledge available today

• Major classes of antibiotics with efficacy

• Bactericide Now Initiative

7/10/2014 www.citrusrdf.org 2

Page 3: Discussion of Penicillin, Antimicrobial R&D and

Requirements for Management

• Slow spread of disease – CHMA and insect control

• Treat existing infected trees

• Protect new plantings

• Provide long-term sustainable genetic and biological solutions

7/10/2014 www.citrusrdf.org 3

Page 4: Discussion of Penicillin, Antimicrobial R&D and

Requirements for Management

• Treat existing infected trees

– Enhanced nutritionals

– Plant growth regulators

– Naturally occurring microbes

– Thermal therapy

– Antibacterial compounds

7/10/2014 www.citrusrdf.org 4

Page 5: Discussion of Penicillin, Antimicrobial R&D and

National Research Council 2010

• Research and Technology Recommendations

• Long-Term Objective 2

– “Support development and testing of bactericides, therapeutics or SAR activators.”

• Less than 5 yrs for “proof of principle and demonstration of HLB mitigation” and greater than 5 yrs for development

7/10/2014 www.citrusrdf.org 5

Page 6: Discussion of Penicillin, Antimicrobial R&D and

SEARCH FOR AGRICULUTRAL THERAPEUTICS

Citrus Greening Disease (Huonglongbing)

7/10/2014 6

Page 7: Discussion of Penicillin, Antimicrobial R&D and

Biological Assays

• Graft-based assay

– Infected scion soaked in test solution and grafted onto uninfected rootstock, follow by PCR

– Slow, low-throughput

– Evidence of efficacy in planta and first look at phyto-toxicity

• Liberibacter crescens culture-based assay

– Much faster, higher-throughput followed by in planta confirmation on CLas

7/10/2014 www.citrusrdf.org 7

Page 8: Discussion of Penicillin, Antimicrobial R&D and

Prior Results

• Compounds screened

– ~100+ by graft graft assay and

– ~400+ by culture assay

• Wide variety of categories of chemicals

– Antibiotics and agricultural antibiotics

– Polycation polymers

– Biopesticides, plant essential oils, terpenoids

– New actives and non-antibiotic derivatives

– Host immune modulators 7/10/2014 www.citrusrdf.org 8

Page 9: Discussion of Penicillin, Antimicrobial R&D and

What are we looking for?

• HLB treatment; effects on tree symptoms through CLas titre reduction

• Sources: Solutions Page, Research, Companies

• Chemical properties– MW: < 450 g/mol preferably < 250 g/mol

– Log Kow: 2 to 4

– pKa: 2 to 6.5 preferably 3 to 5.5

• Volume of phloem: 10 ft tree, 1000 L

• ? pH: 8.0 – 6.0 stylectomy vs fractionation7/10/2014 www.citrusrdf.org 9

Page 10: Discussion of Penicillin, Antimicrobial R&D and

Current Testing Resources

Trunk Injection ➪ Dose

(Dr. Nian Wang)

Citrus Flush Assay on C. asiaticus➪ Confirmation

(Dr. Claudio Gonzalez)

Liquid Culture Assay on L. crescens ➪ MIC90

(Dr. Erik Triplett Laboratory)

7/10/2014 www.citrusrdf.org 10

Page 11: Discussion of Penicillin, Antimicrobial R&D and

Requirements and Results

Trunk Injection ➪ Dose

> 10 gr of material, 2-7 months

Citrus Flush Assay on C. asiaticus➪ Confirmation

~ 100 mg of material, ~ 1 month

Liquid Culture Assay on L. crescens ➪ MIC90

< 1 mg of compound, ~ 2 weeks for results

7/10/2014 www.citrusrdf.org 11

Page 12: Discussion of Penicillin, Antimicrobial R&D and

Top 25 Antibiotics in L. crescens

7/10/2014 www.citrusrdf.org 12

• Criteria used to make the list

– Phloem mobility.

– Inhibits L. crescens at a level of 10μM or less.

– Inhibits growth of L. crescens by at least 98%.

Page 13: Discussion of Penicillin, Antimicrobial R&D and

Antibiotic μM % inhibitionTet #9 0.8 100

Tet #11 1.7 100

Tet #34 5.0 100

Tet #35 5.0 100

Tet #8 8.6 100

demeclocycline 8.6 100

Tet #5 9.8 99.8

oxytetracycline 10.0 99.8

Tet #33 1.0 99.8

Tet #2 2.0 99.8

Top 10 antibiotics; Tetracyclines

Page 14: Discussion of Penicillin, Antimicrobial R&D and

Antibiotic μM % inhibitionTet #9 0.8 100

Tet #11 1.7 100

Tet #34 5.0 100

Tet #35 5.0 100

Tet #8 8.6 100

demeclocycline 8.6 100

Tet #5 9.8 99.8

oxytetracycline 10.0 99.8

Tet #33 1.0 99.8

Tet #2 2.0 99.8

Top 10 antibiotics; Tetracyclines

Page 15: Discussion of Penicillin, Antimicrobial R&D and

Next antibiotics (11-20)Antibiotic μM % inhibition

Tet #18 9.0 99.6

Tet #36 5.0 99.6

Tet #10 1.9 99.4

cephaprin 3.5 99.4

penicillin G 1.8 99.3

cefotaxime 0.7 99.3

penicillin V 0.1 99.1

cefmetazole 4.2 98.9

cefmenoxime 1.2 98.8

ticarcillin 5.2 98.5

Page 16: Discussion of Penicillin, Antimicrobial R&D and

Next antibiotics (21-25)Antibiotic μM % inhibition

ampicillin 0.7 98.5

cefoxitin 4.7 98.4

Tet #24 8.6 98.3

cefdinir 6.3 98.3

cefcapene 1.4 98.3

Page 17: Discussion of Penicillin, Antimicrobial R&D and

BACTERICIDE NOW INITIATIVE

Plans for FY2014-2015

7/10/2014 17

Page 18: Discussion of Penicillin, Antimicrobial R&D and

Possibilities

• Listed in order of increasing regulatory constraints

– GRAS-like and 25(b) minimum risk pesticides

– Commercial antibiotics currently registered for use in food crops

– Copper and Zinc pesticide formulations

– Biopesticides

– “Repurposing” existing products

– Non-antibiotic tetracycline derivatives

7/10/2014 www.citrusrdf.org 18

Page 19: Discussion of Penicillin, Antimicrobial R&D and

THANK-YOU

Contact:

[email protected]

[email protected]

[email protected]

7/10/2014 19